Systemic effect of Tephrosiapurpurea (Sarapunkha) on G.I.T-An Experimental Study
1 Lecturer, KriyaSharir Lalit Hari State, Ayurvedic, College & Hospital,Pilibhit (U.P.)
2 Associate Professor& Head, Deptt. of Kriya Sharir, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi (UP).
Corresponding Author:Dr. Sangeeta Gehlot
Tephrosia purpurea is one of the important drug in Ayurvedic system of medicine extensively used as antipyretic and in diseases of liver,spleen and heart.Recently it has attracted the attention of the scientists all over the world for its hepato-protective and stimulant activity (MAPA, 2001). Two varieties are described in Ayurvedic texts as rakta and sweta. An attempt was made to see g influence of drug on gastro intestinal tract motility in the experimental animals..In group II (drug treated), Tephrosia purpurea Root powder decoction of Tephrosia purpurea was fed by intra gastric route in known doses (0.5 mg/gm body weight ) every morning for 21 days. The control group animals were given water only (equal volume of tap water). Food intake, water intake and weight of rats in control as well as in drug treated group were measured. For the assessment of gut motility of rat, microbar powder suspension administered (a palatable micronized BaSO4 92% w/v from ESKAY fine chemicals) and fasted for 12-14 hours. After 30 minutes of the administration of microbar suspension all the rats were sacrificed simultaneously and measured the BaSO4 powder traveled distance fixed amount of microbar solution. Tephrosiapurpurea enhances intestinal motility in albino rats. Histopathologicalstudy of liver, spleen, and kidney, intestine revealed that Tephrosiapurpurea have no toxic effect.
sellKeywords
format_list_numberedReferences
- Nigam P., Kapoor K.K., Gupta A.K.( 1982). Acute viral hepatitis, Clinico biochemical Studies and Therapeutic efficacy of Tefroli. MAPA, CSIR, 4, 377.
- Medicinal and Aromatic Plants Abstracts (2001) 5, 2897. : BhavPrakashNighantu
- Ramamurthy.,M.R. and Srinivasan. M Indian Journal of Pharmacology. (1993). 25, 34-36. :
- Ramesh R. Ayurvedic Medicinal Plant. ( 2002).
- Sharma B. et al. Phytochemistry. (1982). 21, 1468.
- Sharma, Priyvat (1998), DravyagunaVigyan, 2, 554- 556. : CharakSamhita of Agnivesa, Volume I & II, Fifth Edition, 1997.
- Tripathi Ravi data (2001) on Astang Samgraha.
- TripathiBrahmanand (2003) on AstangHridayam.
- Shastri, AmbikaDutt.( 2002) on SushrutaSamhita)
- Best and Taylor's (1989). Physiological basis of Medical practice. 12th Edition, 620-631.
- Deshpande S., Saha T., Saha G., Parmar N.S. (2005) .A preliminary study on Anti-microbial activity of Tephrosiapurpurea. MAPA, CSIR, 27, 728.
- Dwarkanath, C. (1997) .Digestion and Metabolism in Ayurveda, Second Edition,. 3-5, 11-13, 20-21, 48- 53.
- Ganong, William F.(2003) . Review of Medical Physiology. 21st Edition, 484, 490, 549-555.
- GhanShyamPandey CharakSamhita of Agnivesa, Volume I & II, Fifth Edition, 1997.
- Indian Journal of Chemistry : Volume 39.
- Indian Medicinal plants Volume IV (Sci-Cult. 1978,
- Kritikar K.R., Basu B.D. Indian Medicinal Plants. Second Edition, Volume I, pp. 724-725, 1984.4, 322).
- Sankaran J.R. et al. Tefroli in the management of viral hepatitis. MAPA, CSIR, Vol. 3, No. 2, 1981, p. 12.
How to Cite
Kumar, D. M. & Gehlot, D. S. (2012). Systemic effect of Tephrosiapurpurea (Sarapunkha) on G.I.T-An Experimental Study. International Journal of Ayurvedic and Herbal Medicine, 2(2). https://doi.org/10.47191/ijahm/v2i2.15
American Psychological Association Style